• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Eugia Pharma receives FDA approval for Pazopanib Tablets, 200 mg

    INDPHARMAPOST

    Auro Pharma arm gets USFDA nod for Pazopanib tabs

    BUSINESS STD

    Novugen`s Generic Pazopanib Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of December 20, 2023

    FDA

    Sun Pharma`s Generic Pazopanib Receives Approval in the U.S.

    FDA

    Teva Pharma`s Generic Pazopanib Receives Approval in the U.S.

    FDA

    Health Canda Issues Recall of Pharmascience`s PMS-Pazopanib 200 mg tablet

    HEALTH CANADA

    Xynomic Pharma Achieves Important Regulatory Milestones in China and EU

    PR NEWSWIRE

    Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts

    FIERCE PHARMA

    Xynomic preps broad push for HDAC cancer drug

    FIERCE BIOTECH

    Novartis to Present a Whopping 84 Abstracts at ASCO and EHA

    BIOSPACE

    AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal

    NASDAQ

    CytRx Announces Completion of Enrollment in Pivotal Global Ph3 Trial Ahead

    PR NEWS WIRE

    GSK Deal`s Done. Now, Novartis Has To Deliver On Cancer-Growth Pledge

    FIERCE PHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.